院外心脏骤停昏迷幸存者静脉亚硝酸钠的血流动力学效应
本研究为单中心先导试验,纳入住院的院外心脏骤停昏迷幸存者,比较低剂量亚硝酸钠(1或9.6mg)与安慰剂。结果显示,亚硝酸钠组(n=7)与安慰剂组(n=4)在输注后30分钟内心率(70±20 vs 78±3次/分,p=0.18)、收缩压(103±20 vs 108±15mmHg,p=0.3)及亚铁血红蛋白水平(0.92±0.33 vs 0.70±0.26,p=0.45)均无显著差异。9.6mg亚硝酸钠输注后15分钟内血清亚硝酸盐水平达2-4μM。结论认为低剂量亚硝酸钠未引起显著血流动力学效应,提示可安全用于该危重人群,但需更高剂量才能达到10μM的目标血清水平。
要点
- 在院外心脏骤停昏迷幸存者中,低剂量静脉亚硝酸钠(1或9.6mg)与安慰剂相比,30分钟内心率、收缩压和亚铁血红蛋白无显著差异。
- 9.6mg亚硝酸钠输注后15分钟内血清亚硝酸盐水平达2-4μM,未达到10μM的目标血清水平。
- 亚硝酸钠组(n=7)与安慰剂组(n=4)的收缩压分别为103±20mmHg与108±15mmHg(p=0.3),未达统计学显著。
- 作者认为低剂量亚硝酸钠可安全用于院外心脏骤停后昏迷幸存者,但需更高剂量以达到目标血清水平。
适用人群与场景
- 住院的院外心脏骤停昏迷幸存者(n=7亚硝酸钠组,n=4安慰剂组)。
处置流程与药物剂量
- 静脉输注低剂量亚硝酸钠1或9.6mg;9.6mg输注后15分钟内血清亚硝酸盐水平达2-4μM。
- 目标血清亚硝酸盐水平为10μM,作者认为需更高剂量才能达到。
研究设计与关键结果
- 单中心先导试验,比较低剂量亚硝酸钠(1或9.6mg)与安慰剂在院外心脏骤停昏迷幸存者中的血流动力学效应。
- 输注后30分钟内心率:亚硝酸钠组70±20次/分 vs 安慰剂组78±3次/分,p=0.18,无显著差异。
- 收缩压:亚硝酸钠组103±20mmHg vs 安慰剂组108±15mmHg,p=0.3,无显著差异。
- 亚铁血红蛋白水平:亚硝酸钠组0.92±0.33 vs 安慰剂组0.70±0.26,p=0.45,无显著差异。
- 9.6mg亚硝酸钠输注后15分钟内血清亚硝酸盐水平达2-4μM。
证据类型、等级与局限
- 证据类型:单中心先导试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为低剂量亚硝酸钠(1或9.6mg)可安全用于院外心脏骤停后昏迷幸存者,未引起显著血流动力学效应。
- 作者指出需更高剂量亚硝酸钠以达到10μM的目标血清水平。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients resuscitated from cardiac arrest have brain and cardiac injury. Recent animal studies suggest that the administration of sodium nitrite after resuscitation from 12min of asystole limits acute cardiac dysfunction and improves survival and neurologic outcomes. It has been hypothesized that low doses of IV sodium nitrite given during resuscitation of out of hospital cardiac arrest (OHCA) will improve survival. Low doses of sodium nitrite (e.g., 9.6mg of sodium nitrite) are safe in healthy individuals, however the effect of nitrite on blood pressure in resuscitated cardiac arrest patients is unknown.
METHODS: We performed a single-center, pilot trial of low dose sodium nitrite (1 or 9.6mg dose) vs. placebo in hospitalized out-of-hospital cardiac arrest patient to determine whether nitrite administration reduced blood pressure and whether whole blood nitrite levels increased in response to nitrite administration.
RESULTS: This is the first reported study of sodium nitrite in cardiac arrest patients. Infusion of low doses of sodium nitrite in comatose survivors of OHCA (n=7) compared to placebo (n=4) had no significant effects on heart rate within 30min after infusion (70±20 vs. 78±3 beats per minute, p=0.18), systolic blood pressure (103±20 vs 108±15mmHg, p=0.3), or methemoglobin levels (0.92±0.33 vs. 0.70±0.26, p=0.45). Serum nitrite levels of 2-4μM were achieved within 15min of a 9.6mg nitrite infusion.
CONCLUSIONS: Low dose sodium nitrite does not cause significant hemodynamic effect in patients with OHCA, which suggests that nitrite can be delivered safely in this critically ill patient population. Higher doses of sodium nitrite are necessary in order to achieve target serum level of 10μM.
参考来源
- Dezfulian C, Olsufka M, Fly D, et al. Hemodynamic effects of IV sodium nitrite in hospitalized comatose survivors of out of hospital cardiac arrest. Resuscitation. 2017. PMID: 29175357. doi:10.1016/j.resuscitation.2017.11.055
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。